Market Closed

DYN
Dyne Therapeutics
$ 17.16
0.88%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Dyne Therapeutics News

Latest Dyne Therapeutics Stock News & DYN Headlines

Dyne Therapeutics to Participate in Upcoming Investor Conference
5 days ago | globenewswire.com
Dyne Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights
11 days ago | globenewswire.com
Dyne Therapeutics Announces Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)
2 months ago | globenewswire.com
Dyne Therapeutics, Inc. (DYN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
2 months ago | seekingalpha.com
Stock Traders Buy High Volume of Dyne Therapeutics Call Options (NASDAQ:DYN)
2 months ago | defenseworld.net
Dyne Therapeutics to Present Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1) at Upcoming Medical Meetings
2 months ago | globenewswire.com
Dyne Therapeutics, Inc. $DYN is Atlas Venture Life Science Advisors LLC’s 2nd Largest Position
2 months ago | defenseworld.net
Dyne Therapeutics to Present Preclinical Data for Multiple Development Candidates for Duchenne Muscular Dystrophy (DMD) at 27th Annual NMSG Scientific Meeting
2 months ago | globenewswire.com
Dyne Therapeutics to Participate in Upcoming Investor Conferences
2 months ago | globenewswire.com
ADAR1 Capital Management LLC Buys Shares of 42,821 Dyne Therapeutics, Inc. $DYN
3 months ago | defenseworld.net
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

DYN
Dyne Therapeutics
$ 17.16
0.88%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago